View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Acute Kidney Injury News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 22, 2021
2 min read
Save

FDA approves Lupkynis, first-ever oral therapy for lupus nephritis

FDA approves Lupkynis, first-ever oral therapy for lupus nephritis

The FDA has approved voclosporin as the first oral treatment for lupus nephritis in adult patients who are receiving background immunosuppressive therapy, according to a press release from Aurinia Pharmaceuticals.

SPONSORED CONTENT
January 20, 2021
2 min read
Save

Stress-related disorders linked to kidney disease progression, AKI

Stress-related disorders linked to kidney disease progression, AKI

Swedish patients who had a stress-related disorder were more likely to experience chronic kidney disease progression and AKI compared with a population-matched control group.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
January 19, 2021
5 min read
Save

‘Smaller, simpler, smarter’: Quanta officials review FDA-cleared portable dialysis system

‘Smaller, simpler, smarter’: Quanta officials review FDA-cleared portable dialysis system

Already commercially available in the United Kingdom, the SC+ portable hemodialysis system from Quanta Dialysis Technologies has received 510(k) clearance “setting the stage for [a] U.S. market launch,” according to a press release.

SPONSORED CONTENT
January 15, 2021
1 min read
Save

Transplanted kidneys from deceased donors with terminal AKI found safe, effective

Kidney transplantation with organs from donors who died after developing AKI conferred similar outcomes as transplant with non-AKI organs, according to study results.

SPONSORED CONTENT
January 08, 2021
1 min read
Save

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

For patients with type 2 diabetes, SGLT2 inhibitors conferred a lower risk of developing AKI than use of GLP-1 receptor agonists or dipeptidyl peptidase-4 inhibitors, according to a network meta-analysis of clinical trials.

SPONSORED CONTENT
December 17, 2020
2 min read
Save

FDA approves Benlysta, first treatment for lupus nephritis

FDA approves Benlysta, first treatment for lupus nephritis

The FDA has approved belimumab in intravenous and subcutaneous formulations for the treatment of lupus nephritis in adult patients who are receiving standard therapy, according to a press release from GlaxoSmithKline.

SPONSORED CONTENT
December 03, 2020
1 min read
Save

Study finds 30% of patients with AKI do not receive adequate follow-up

Research presented at the virtual ASN Kidney Week suggested 30% of patients hospitalized with AKI received inadequate follow-up, with medical risk factors being the “primary determinants” of care after hospitalization.

SPONSORED CONTENT
November 18, 2020
2 min read
Save

Acute kidney injury with COVID-19 shows potential for ‘lifetime’ impact

Acute kidney injury with COVID-19 shows potential for ‘lifetime’ impact

A study of U.S. veterans hospitalized with COVID-19 showed 32% developed AKI, with many not fully recovering kidney function by discharge. Black individuals were at greatest risk for AKI and resulting mortality.

SPONSORED CONTENT
November 17, 2020
3 min read
Save

Belimumab plus standard therapy boosts renal outcomes, reduces steroids in lupus nephritis

Belimumab plus standard therapy boosts renal outcomes, reduces steroids in lupus nephritis

Adding belimumab to standard therapy improves renal outcomes, biomarker levels and overall disease activity among patients with lupus nephritis, according to a speaker at ACR Convergence 2020.

SPONSORED CONTENT
November 16, 2020
1 min read
Save

Machine-learning tool may help predict acute kidney injury in patients with COVID-19

Machine-learning tool may help predict acute kidney injury in patients with COVID-19

Researchers from Icahn School of Medicine at Mount Sinai found a machine-learning model performed well in predicting risk for AKI and need for dialysis in patients hospitalized with COVID-19.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails